デジタル神経バイオマーカーの世界市場：市場規模・シェア・動向分析 (種類別・診療行為別・最終用途別・地域別・セグメント別、2025年～2030年)

デジタル神経バイオマーカー市場の成長と動向：

デジタル神経バイオマーカーの世界市場規模は、2030年には28億2,000万米ドルに達すると予測され、2025年から2030年にかけてCAGR 25.7%で成長すると予測されています。

神経疾患の有病率の増加、世界の高齢者人口の増加、技術の進歩、個別化医療の需要、民間および公的企業による市場への投資の増加など、さまざまな要因によって市場は大きな成長を遂げています。さらに、デジタルヘルス技術に対する規制当局の承認や償還範囲の拡大が、デジタル神経バイオマーカーの採用を後押ししています。規制機関は、患者の転帰を改善するこれらの技術の可能性を認識しており、支持的な政策や償還モデルにつながっています。

アルツハイマー病、パーキンソン病、多発性硬化症などの神経疾患の有病率の増加は、デジタル神経バイオマーカーの需要を大きく促進しています。これらの複雑な疾患では、症状を効果的に管理し、患者の転帰を改善するために、正確で継続的なモニタリングと早期発見が必要です。デジタル神経バイオマーカーは、ウェアラブルセンサーやモバイルヘルスアプリケーションなどの高度な技術を通じて、神経機能や疾患の進行を正確に追跡します。リアルタイムのデータと洞察を提供することで、これらのバイオマーカーは早期介入と個別化された治療戦略を可能にし、神経疾患のタイムリーで的を絞った管理という重要なニーズに対応します。例えば、米国では100万人近くが多発性硬化症 (MS) の影響を受けています。全米多発性硬化症協会によると、世界全体では280万人以上がMSとともに生きていると推定されています。MSと診断されるのは20～50歳が多いが、年齢に関係なく発症する可能性があります。また、MSは男性に比べて女性に多く診断されます。

神経疾患の早期発見と予防が重視されるようになってきています。デジタル神経バイオマーカーは、従来の方法よりも早い段階で疾患マーカーを検出できるため、タイムリーな介入と管理が可能になるという利点があります。AIと機械学習の統合も市場成長の原動力となっており、例えば2022年9月、Nutromics社は「lab-in-a-patch」プラットフォームを推進するため、Dexcom Ventures社から1,400万米ドルの資金を確保しました。この革新的な技術はDNAセンサーを利用し、疾患バイオマーカーや課題治療薬を含む様々なターゲットをモニターします。さらに、デジタル神経バイオマーカーを、電子カルテ (EHR) や遠隔医療など、より広範なデジタルヘルスプラットフォームと統合することで、その有用性とアクセシビリティが高まる。この統合により、継続的なモニタリングとリアルタイムのデータ分析が容易になり、患者のケアと転帰が改善されます。例えば、2021年10月、高度な神経疾患診断の開発に取り組むAI企業であるアルトイダ社は、5年間の多施設観察研究を開始しました。この広範な研究は、アルツハイマー病の全段階にわたる数千人の患者を対象とし、疾患連続体の理解と診断能力の向上を目指します。

主要企業は、合併、買収、製品発売など、競争力を維持するために様々な戦略を採用しています。主要な市場参入企業による主な戦略的イニシアチブは以下の通りです：

• 2024年4月、Tris Pharma Inc.はBraingaze Ltd.とライセンス契約を締結し、Tris Digital Healthを設立しました。この新部門は、注意欠陥・多動性障害 (ADHD) やその他の神経疾患のデジタル診断・治療製品の開発と販売に注力します。
• 2024年3月、クムルス・ニューロサイエンス社は、イノベートUK SBRI (中小企業研究イニシアティブ) から約125万米ドルの助成金を授与されました。この資金は、血液バイオマーカーの精度を高めるために設計されたAI診断ツールの開発と検証をサポートします。新しいAIアルゴリズムは、血液バイオマーカーと、Cumulus Neuroassessment Platformを通じて得られるデジタルバイオマーカーおよび人口統計学的情報を統合します。
• 2024年1月、ハーバード大学ジョン・A・ポールソン・スクール・オブ・エンジニアリング・アンド・アプライド・サイエンス、ボストン大学サージェント・カレッジ・オブ・ヘルス＆リハビリテーション・サイエンス、ハーバード大学ウィス研究所の研究開発者らは、パーキンソン病患者のスムーズな歩行を支援するために設計された、ソフトでウェアラブルなロボットを開発しました。この革新的なロボット衣服は、太ももと臀部に装着することで、脚を振るたびに臀部を優しく押してくれます。このサポートにより、患者の歩幅が長くなり、固まることが少なくなり、可動性と全体的な歩行能力が向上します。

デジタル神経バイオマーカー市場：分析概要

• 種類別では、ウェアラブルセグメントが2024年に39.9%の最大収益シェアで市場を独占しました。モバイルベースアプリケーションセグメントは予測期間中最も速いCAGRが見込まれます。
• 診療行為に基づくと、診断用デジタル神経バイオマーカー分野が2024年に30%以上の最大市場シェアを占めました。モニタリングセグメントは、予測期間中に最も速いCAGRで示される見込みです。
• 最終用途に基づくと、医療企業セグメントは2024年に47.5%と大半のシェアを占めました。医療提供者分野は、予測期間中に最も速いCAGRで示される見込みです。
• 北米デジタル神経バイオマーカー市場は、2024年に37.7%の収益シェアで市場を独占しました。神経疾患の診断ニーズの高まりにより、神経バイオマーカーの需要が大幅に増加しています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 デジタル神経バイオマーカー市場の変数、動向、範囲

• 市場系統の見通し
  • 親市場の見通し
  • 関連/付随市場の見通し
• 市場力学
  • 市場ドライバー分析
  • 市場抑制要因分析
• デジタル神経バイオマーカー市場分析ツール
  • 業界分析- ポーターのファイブフォース分析
  • PESTEL分析
  • テクノロジータイムラインと製品パイプライン分析
  • ケーススタディ分析/エンド使用事例分析

第4章 デジタル神経バイオマーカー市場：種類別の推定・動向分析

• セグメントダッシュボード
• デジタル神経バイオマーカー市場の変動分析：種類別
• デジタル神経バイオマーカー市場の展望：種類別
• ウェアラブル
• モバイルベースのアプリケーション
• センサー
• その他

第5章 デジタル神経バイオマーカー市場：診療行為別の推定・動向分析

• セグメントダッシュボード
• デジタル神経バイオマーカー市場の変動分析：診療行為別
• デジタル神経バイオマーカー市場の展望：診療行為別
• 診断用デジタル神経バイオマーカー
• モニタリング用デジタル神経バイオマーカー
• 予測・予後用デジタル神経バイオマーカー
• その他

第6章 デジタル神経バイオマーカー市場：最終用途別の推定・動向分析

• セグメントダッシュボード
• デジタル神経バイオマーカー市場の変動分析：最終用途別
• デジタル神経バイオマーカー市場の展望：最終用途別
• 医療企業
• 医療提供者
• 医療保険支払者
• その他

第7章 デジタル神経バイオマーカー市場：地域別の推定・動向分析

• 地域別のダッシュボード
• デジタル神経バイオマーカー市場の変動分析：地域別
• デジタル神経バイオマーカー市場：地域別の推定・動向分析 (種類別・診療行為別・最終用途別)
• 市場規模の予測と動向分析 (2018～2030年)
• 北米
  • 米国
  • カナダ
  • メキシコ
  • 欧州
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • デンマーク
  • ノルウェー
  • スウェーデン
• アジア太平洋
  • 日本
  • 中国
  • インド
  • 韓国
  • オーストラリア
  • タイ
• ラテンアメリカ
  • ブラジル
  • アルゼンチン
• 中東・アフリカ
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第8章 競合情勢

• 市場参入企業の分類
• 主要企業のプロファイル
  • Altoida Inc.
  • Koneksa
  • Biogen Inc.
  • Roche (Navify)
  • NeuraMetrix
  • Merck KGaA
  • Linus Health
  • Neurotrack Technologies, Inc.
  • Huma
  • NeuraLight

List of Tables

• Table 1 List of Secondary Sources
• Table 2 List of Abbreviations
• Table 3 Global digital neuro biomarkers market, by type, 2018 - 2030 (USD Million)
• Table 4 Global digital neuro biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
• Table 5 Global digital neuro biomarkers market, by end use, 2018 - 2030 (USD Million)
• Table 6 North America digital neuro biomarkers market, by country, 2018 - 2030 (USD Million)
• Table 7 North America digital neuro biomarkers market, by type, 2018 - 2030 (USD Million)
• Table 8 North America digital neuro biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
• Table 9 North America digital neuro biomarkers market, by end use, 2018 - 2030 (USD Million)
• Table 10 U.S. digital neuro biomarkers market, by type, 2018 - 2030 (USD Million)
• Table 11 U.S. digital neuro biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
• Table 12 U.S. digital neuro biomarkers market, by end use, 2018 - 2030 (USD Million)
• Table 13 Canada digital neuro biomarkers market, by type, 2018 - 2030 (USD Million)
• Table 14 Canada digital neuro biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
• Table 15 Canada digital neuro biomarkers market, by end use, 2018 - 2030 (USD Million)
• Table 16 Mexico digital neuro biomarkers market, by type, 2018 - 2030 (USD Million)
• Table 17 Mexico digital neuro biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
• Table 18 Mexico digital neuro biomarkers market, by end use, 2018 - 2030 (USD Million)
• Table 19 Europe digital neuro biomarkers market, by country, 2018 - 2030 (USD Million)
• Table 20 Europe digital neuro biomarkers market, by type, 2018 - 2030 (USD Million)
• Table 21 Europe digital neuro biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
• Table 22 Europe digital neuro biomarkers market, by end use, 2018 - 2030 (USD Million)
• Table 23 UK digital neuro biomarkers market, by type, 2018 - 2030 (USD Million)
• Table 24 UK digital neuro biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
• Table 25 UK digital neuro biomarkers market, by end use, 2018 - 2030 (USD Million)
• Table 26 Germany digital neuro biomarkers market, by type, 2018 - 2030 (USD Million)
• Table 27 Germany digital neuro biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
• Table 28 Germany digital neuro biomarkers market, by end use, 2018 - 2030 (USD Million)
• Table 29 France digital neuro biomarkers market, by type, 2018 - 2030 (USD Million)
• Table 30 France digital neuro biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
• Table 31 France digital neuro biomarkers market, by end use, 2018 - 2030 (USD Million)
• Table 32 Italy digital neuro biomarkers market, by type, 2018 - 2030 (USD Million)
• Table 33 Italy digital neuro biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
• Table 34 Italy digital neuro biomarkers market, by end use, 2018 - 2030 (USD Million)
• Table 35 Spain digital neuro biomarkers market, by type, 2018 - 2030 (USD Million)
• Table 36 Spain digital neuro biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
• Table 37 Spain digital neuro biomarkers market, by end use, 2018 - 2030 (USD Million)
• Table 38 Denmark digital neuro biomarkers market, by type, 2018 - 2030 (USD Million)
• Table 39 Denmark digital neuro biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
• Table 40 Denmark digital neuro biomarkers market, by end use, 2018 - 2030 (USD Million)
• Table 41 Norway digital neuro biomarkers market, by type, 2018 - 2030 (USD Million)
• Table 42 Norway digital neuro biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
• Table 43 Norway digital neuro biomarkers market, by end use, 2018 - 2030 (USD Million)
• Table 44 Sweden digital neuro biomarkers market, by type, 2018 - 2030 (USD Million)
• Table 45 Sweden digital neuro biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
• Table 46 Sweden digital neuro biomarkers market, by end use, 2018 - 2030 (USD Million)
• Table 47 Asia Pacific digital neuro biomarkers market, by type, 2018 - 2030 (USD Million)
• Table 48 Asia Pacific digital neuro biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
• Table 49 Asia Pacific digital neuro biomarkers market, by end use, 2018 - 2030 (USD Million)
• Table 50 China digital neuro biomarkers market, by type, 2018 - 2030 (USD Million)
• Table 51 China digital neuro biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
• Table 52 China digital neuro biomarkers market, by end use, 2018 - 2030 (USD Million)
• Table 53 Japan digital neuro biomarkers market, by type, 2018 - 2030 (USD Million)
• Table 54 Japan digital neuro biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
• Table 55 Japan digital neuro biomarkers market, by end use, 2018 - 2030 (USD Million)
• Table 56 India digital neuro biomarkers market, by type, 2018 - 2030 (USD Million)
• Table 57 India digital neuro biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
• Table 58 India digital neuro biomarkers market, by end use, 2018 - 2030 (USD Million)
• Table 59 Australia digital neuro biomarkers market, by type, 2018 - 2030 (USD Million)
• Table 60 Australia digital neuro biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
• Table 61 Australia digital neuro biomarkers market, by end use, 2018 - 2030 (USD Million)
• Table 62 South Korea digital neuro biomarkers market, by type, 2018 - 2030 (USD Million)
• Table 63 South Korea digital neuro biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
• Table 64 South Korea digital neuro biomarkers market, by end use, 2018 - 2030 (USD Million)
• Table 65 Thailand digital neuro biomarkers market, by type, 2018 - 2030 (USD Million)
• Table 66 Thailand digital neuro biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
• Table 67 Thailand digital neuro biomarkers market, by end use, 2018 - 2030 (USD Million)
• Table 68 Latin America digital neuro biomarkers market, by country, 2018 - 2030 (USD Million)
• Table 69 Latin America digital neuro biomarkers market, by type, 2018 - 2030 (USD Million)
• Table 70 Latin America digital neuro biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
• Table 71 Latin America digital neuro biomarkers market, by end use, 2018 - 2030 (USD Million)
• Table 72 Brazil digital neuro biomarkers market, by type, 2018 - 2030 (USD Million)
• Table 73 Brazil digital neuro biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
• Table 74 Brazil digital neuro biomarkers market, by end use, 2018 - 2030 (USD Million)
• Table 75 Argentina digital neuro biomarkers market, by type, 2018 - 2030 (USD Million)
• Table 76 Argentina digital neuro biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
• Table 77 Argentina digital neuro biomarkers market, by end use, 2018 - 2030 (USD Million)
• Table 78 MEA digital neuro biomarkers market, by country, 2018 - 2030 (USD Million)
• Table 79 MEA digital neuro biomarkers market, by type, 2018 - 2030 (USD Million)
• Table 80 MEA digital neuro biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
• Table 81 MEA digital neuro biomarkers market, by end use, 2018 - 2030 (USD Million)
• Table 82 South Africa digital neuro biomarkers market, by type, 2018 - 2030 (USD Million)
• Table 83 South Africa digital neuro biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
• Table 84 South Africa digital neuro biomarkers market, by end use, 2018 - 2030 (USD Million)
• Table 85 Saudi Arabia digital neuro biomarkers market, by type, 2018 - 2030 (USD Million)
• Table 86 Saudi Arabia digital neuro biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
• Table 87 Saudi Arabia digital neuro biomarkers market, by end use, 2018 - 2030 (USD Million)
• Table 88 UAE digital neuro biomarkers market, by type, 2018 - 2030 (USD Million)
• Table 89 UAE digital neuro biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
• Table 90 UAE digital neuro biomarkers market, by end use, 2018 - 2030 (USD Million)
• Table 91 Kuwait digital neuro biomarkers market, by type, 2018 - 2030 (USD Million)
• Table 92 Kuwait digital neuro biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
• Table 93 Kuwait digital neuro biomarkers market, by end use, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Information procurement
• Fig. 2 Primary research pattern
• Fig. 3 Market research approaches
• Fig. 4 Value chain-based sizing & forecasting
• Fig. 5 Market formulation & validation
• Fig. 6 Digital neuro biomarkers market segmentation
• Fig. 7 Market driver analysis (current & future impact)
• Fig. 8 Market restraint analysis (current & future impact)
• Fig. 9 SWOT analysis, by factor (political & legal, economic and technological)
• Fig. 10 Porter's five forces analysis
• Fig. 11 Digital neuro biomarkers market, type outlook key takeaways (USD Million)
• Fig. 12 Digital neuro biomarkers market: type movement analysis 2024 & 2030 (USD Million)
• Fig. 13 Wearable market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 14 Mobile based applications market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 15 Sensors market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 16 Others market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 17 Digital neuro biomarkers market, clinical practice outlook key takeaways (USD Million)
• Fig. 18 Digital neuro biomarkers market: clinical practice movement analysis 2024 & 2030 (USD Million)
• Fig. 19 Diagnostic psychiatric digital biomarkers market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 20 Monitoring psychiatric digital biomarkers market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 21 Predictive and prognostic psychiatric digital biomarkers market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 22 Others market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 23 Digital neuro biomarkers market, end use outlook key takeaways (USD Million)
• Fig. 24 Digital neuro biomarkers market: end use movement analysis 2024 & 2030 (USD Million)
• Fig. 25 Healthcare companies market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 26 Healthcare providers market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 27 Payers market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 28 Others market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 29 Digital neuro biomarkers market: regional key takeaways (USD Million)
• Fig. 30 Digital neuro biomarkers market: regional outlook, 2024 & 2030, USD Million
• Fig. 31 North America Digital neuro biomarkers market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 32 U.S. Digital neuro biomarkers market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 33 Canada Digital neuro biomarkers market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 34 Mexico Digital neuro biomarkers market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 35 Europe Digital neuro biomarkers market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 36 UK Digital neuro biomarkers market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 37 Germany Digital neuro biomarkers market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 38 France Digital neuro biomarkers market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 39 Spain Digital neuro biomarkers market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 40 Italy Digital neuro biomarkers market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 41 Norway Digital neuro biomarkers market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 42 Denmark Digital neuro biomarkers market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 43 Sweden Digital neuro biomarkers market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 44 Asia Pacific Digital neuro biomarkers market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 45 China Digital neuro biomarkers market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 46 Japan Digital neuro biomarkers market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 47 India Digital neuro biomarkers market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 48 South Korea Digital neuro biomarkers market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 49 Australia Digital neuro biomarkers market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 50 Thailand Digital neuro biomarkers market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 51 Latin America Digital neuro biomarkers market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 52 Brazil Digital neuro biomarkers market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 53 Argentina Digital neuro biomarkers market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 54 Middle East and Africa Digital neuro biomarkers market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 55 South Africa Digital neuro biomarkers market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 56 Saudi Arabia Digital neuro biomarkers market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 57 UAE Digital neuro biomarkers market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 58 Kuwait Digital neuro biomarkers market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 59 List of key emerging company's/technology disruptors/innovators

Digital Neuro Biomarkers Market Growth & Trends:

The global digital neuro biomarkers market size is anticipated to reach USD 2.82 billion in 2030 and is projected to grow at a CAGR of 25.7% from 2025 to 2030. The market is witnessing significant growth owing to various factors such as increased prevalence of neurological disorders, rising geriatric population globally, advances in technology, demand for personalized medicine, and increased investment in the market by private and public players. Furthermore, positive regulatory approvals and increasing reimbursement coverage for digital health technologies encourage the adoption of digital neuro biomarkers. Regulatory bodies are recognizing the potential of these technologies to improve patient outcomes, leading to supportive policies and reimbursement models.

The increasing prevalence of neurological disorders such as Alzheimer's disease, Parkinson's disease, and multiple sclerosis is significantly fueling the demand for digital neuro biomarkers. These complex conditions necessitate accurate, continuous monitoring and early detection to manage symptoms effectively and improve patient outcomes. Digital neuro biomarkers, through advanced technologies such as wearable sensors and mobile health applications, offer precise tracking of neurological functions and disease progression. By providing real-time data and insights, these biomarkers enable early intervention and personalized treatment strategies, addressing the critical need for timely and targeted management of neurological conditions. For instance, in the U.S., close to 1 million individuals are impacted by multiple sclerosis (MS). Globally, it is estimated that over 2.8 million people are living with MS, according to the National Multiple Sclerosis Society. While most MS diagnoses occur between the ages of 20 and 50, the condition can affect individuals at any age. In addition, MS is more commonly diagnosed in women compared to men.

There is a growing emphasis on early detection and prevention of neurological diseases. Digital neuro biomarkers offer the advantage of detecting disease markers at an earlier stage than traditional methods, allowing for timely intervention and management. Integration of AI and machine learning is also driving the market growth, for instance, in September 2022, Nutromics secured USD 14 million in funding from Dexcom Ventures to advance its 'lab-in-a-patch' platform. This innovative technology utilizes DNA sensors to monitor a range of targets, including disease biomarkers and challenging-to-dose medications. Moreover, the integration of digital neuro biomarkers with broader digital health platforms, including electronic health records (EHRs) and telemedicine, enhances their utility and accessibility. This integration facilitates continuous monitoring and real-time data analysis, improving patient care and outcomes. For instance, In October 2021, Altoida, Inc., an AI company at developing advanced neurological disease diagnostics, launched a five-year multicenter observational study. This extensive study will involve thousands of patients across all stages of Alzheimer's disease, aiming to enhance the understanding and diagnostic capabilities of the disease continuum.

Key players are adopting various strategies to maintain a competitive edge such as mergers, acquisition, product launches, etc. Some of the key strategic initiatives by the major market players include:

• In April 2024, Tris Pharma Inc. entered into a licensing agreement with Braingaze Ltd. and established Tris Digital Health. This new division will focus on the development and distribution of digital diagnostic and therapeutic products for attention-deficit/hyperactivity disorder (ADHD) and other neurological health conditions
• In March 2024, Cumulus Neuroscience was awarded a grant of nearly USD 1.25 million from the Innovate UK SBRI (Small Business Research Initiative). This funding will support the development and validation of an AI diagnostic tool designed to enhance the accuracy of blood biomarkers. The new AI algorithms will integrate blood biomarkers with digital biomarkers-obtained through the Cumulus Neuroassessment Platform-and demographic information
• In January 2024, Researchers from the Harvard John A. Paulson School of Engineering and Applied Sciences, Boston University Sargent College of Health & Rehabilitation Sciences, and the Wyss Institute at Harvard University developed a soft, wearable robot designed to assist individuals with Parkinson's disease in walking more smoothly. This innovative robotic garment, which is worn around the thighs and hips, provides a gentle push to the hips during each leg swing. This support helps the patient achieve a longer stride and reduces instances of freezing, improving mobility and overall walking ability

Digital Neuro Biomarkers Market Report Highlights:

• Based on type, the wearable segment dominated the market with the largest revenue share of 39.9% in 2024. The mobile-based application segment is expected to witness the fastest CAGR over the forecast period.
• Based on clinical practice, the diagnostic digital neuro biomarkers segment held the largest market share of over 30% in 2024. The monitoring segment is expected to witness at the fastest CAGR over the forecast period
• Based on end use, the healthcare companies segment held the majority of share of 47.5% in 2024. The healthcare providers segment is expected to witness at the fastest CAGR over the forecast period
• North America digital neuro biomarkers market dominated the market with a revenue share of 37.7% in 2024. The rising need for diagnosing neurological disorders has significantly increased the demand for neurological biomarkers

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Segment Definitions
  • 1.2.1. Type
  • 1.2.2. Clinical Practice
  • 1.2.3. End Use
  • 1.2.4. Regional Scope
  • 1.2.5. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Type outlook
  • 2.2.2. Clinical practice outlook
  • 2.2.3. End Use outlook
• 2.3. Regional outlook
• 2.4. Competitive Insights

Chapter 3. Digital Neuro Biomarkers Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
  • 3.2.2. Market Restraint Analysis
• 3.3. Digital Neuro Biomarkers Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitutes
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Economic landscape
    • 3.3.2.3. Social landscape
    • 3.3.2.4. Technological landscape
    • 3.3.2.5. Environmental landscape
    • 3.3.2.6. Legal landscape
  • 3.3.3. Technology Timeline & Product Pipeline Analysis
  • 3.3.4. Case Study Analysis/ End Use Case Analysis

Chapter 4. Digital Neuro Biomarkers Market: Type Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Digital Neuro Biomarkers Market: Type Movement Analysis
• 4.3. Digital Neuro Biomarkers Market by Type Outlook (USD Million)
• 4.4. Wearables
  • 4.4.1. Wearables Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.5. Mobile based Applications
  • 4.5.1. Mobile based Applications Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.6. Sensors
  • 4.6.1. Sensors Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.7. Others
  • 4.7.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Digital Neuro Biomarkers Market: Clinical Practice Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Digital Neuro Biomarkers Market: Clinical Practice Movement Analysis
• 5.3. Digital Neuro Biomarkers Market by Clinical Practice Outlook (USD Million)
• 5.4. Diagnostic Digital Neuro Biomarkers
  • 5.4.1. Diagnostic Digital Neuro Biomarkers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.5. Monitoring Digital Neuro Biomarkers
  • 5.5.1. Monitoring Digital Neuro Biomarkers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.6. Predictive and Prognostic Digital Neuro Biomarkers
  • 5.6.1. Predictive and Prognostic Digital Neuro Biomarkers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.7. Others
  • 5.7.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Digital Neuro Biomarkers Market: End Use Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Digital Neuro Biomarkers Market: End Use Movement Analysis
• 6.3. Digital Neuro Biomarkers Market by End Use Outlook (USD Million)
• 6.4. Healthcare companies
  • 6.4.1. Healthcare companies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.5. Healthcare Providers
  • 6.5.1. Healthcare Providers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.6. Payers
  • 6.6.1. Payers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.7. Others
  • 6.7.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Digital Neuro Biomarkers Market: Regional Estimates & Trend Analysis

• 7.1. Regional Dashboard
• 7.2. Regional Digital Neuro Biomarkers Market movement analysis
• 7.3. Digital Neuro Biomarkers Market: Regional Estimates & Trend Analysis by Type, Clinical Practice & End-use
• 7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 7.5. North America
  • 7.5.1. North America Digital Neuro Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.2. U.S.
    • 7.5.2.1. U.S. Digital Neuro Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.3. Canada
    • 7.5.3.1. Canada Digital Neuro Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.4. Mexico
    • 7.5.4.1. Mexico Digital Neuro Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.5. Europe
  • 7.5.6. Europe Digital Neuro Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.7. UK
    • 7.5.7.1. UK Digital Neuro Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.8. Germany
    • 7.5.8.1. Germany Digital Neuro Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.9. France
    • 7.5.9.1. France Digital Neuro Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.10. Italy
    • 7.5.10.1. Italy Digital Neuro Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.11. Spain
    • 7.5.11.1. Spain Digital Neuro Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.12. Denmark
    • 7.5.12.1. Denmark Digital Neuro Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.13. Norway
    • 7.5.13.1. Norway Digital Neuro Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.14. Sweden
    • 7.5.14.1. Sweden Digital Neuro Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.6. Asia Pacific
  • 7.6.1. Asia Pacific Digital Neuro Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.2. Japan
    • 7.6.2.1. Japan Digital Neuro Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.3. China
    • 7.6.3.1. China Digital Neuro Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.4. India
    • 7.6.4.1. India Digital Neuro Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.5. South Korea
    • 7.6.5.1. South Korea Digital Neuro Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.6. Australia
    • 7.6.6.1. Australia Digital Neuro Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.7. Thailand
    • 7.6.7.1. Thailand Digital Neuro Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.7. Latin America
  • 7.7.1. Latin America Digital Neuro Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7.2. Brazil
    • 7.7.2.1. Brazil Digital Neuro Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7.3. Argentina
    • 7.7.3.1. Argentina Digital Neuro Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.8. Middle East & Africa
  • 7.8.1. Middle East & Africa Digital Neuro Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8.2. South Africa
    • 7.8.2.1. South Africa Digital Neuro Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8.3. Saudi Arabia
    • 7.8.3.1. Saudi Arabia Digital Neuro Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8.4. UAE
    • 7.8.4.1. UAE Digital Neuro Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8.5. Kuwait
    • 7.8.5.1. Kuwait Digital Neuro Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Market Participant Categorization
• 8.2. Key Company Profiles
  • 8.2.1. Altoida Inc.
    • 8.2.1.1. Company overview
    • 8.2.1.2. Financial performance
    • 8.2.1.3. Product benchmarking
    • 8.2.1.4. Strategic initiatives
  • 8.2.2. Koneksa
    • 8.2.2.1. Company overview
    • 8.2.2.2. Financial performance
    • 8.2.2.3. Product benchmarking
    • 8.2.2.4. Strategic initiatives
  • 8.2.3. Biogen Inc.
    • 8.2.3.1. Company overview
    • 8.2.3.2. Financial performance
    • 8.2.3.3. Product benchmarking
    • 8.2.3.4. Strategic initiatives
  • 8.2.4. Roche (Navify)
    • 8.2.4.1. Company overview
    • 8.2.4.2. Financial performance
    • 8.2.4.3. Product benchmarking
    • 8.2.4.4. Strategic initiatives
  • 8.2.5. NeuraMetrix
    • 8.2.5.1. Company overview
    • 8.2.5.2. Financial performance
    • 8.2.5.3. Product benchmarking
    • 8.2.5.4. Strategic initiatives
  • 8.2.6. Merck KGaA
    • 8.2.6.1. Company overview
    • 8.2.6.2. Financial performance
    • 8.2.6.3. Product benchmarking
    • 8.2.6.4. Strategic initiatives
  • 8.2.7. Linus Health
    • 8.2.7.1. Company overview
    • 8.2.7.2. Financial performance
    • 8.2.7.3. Product benchmarking
    • 8.2.7.4. Strategic initiatives
  • 8.2.8. Neurotrack Technologies, Inc.
    • 8.2.8.1. Company overview
    • 8.2.8.2. Financial performance
    • 8.2.8.3. Product benchmarking
    • 8.2.8.4. Strategic initiatives
  • 8.2.9. Huma
    • 8.2.9.1. Company overview
    • 8.2.9.2. Financial performance
    • 8.2.9.3. Product benchmarking
    • 8.2.9.4. Strategic initiatives
  • 8.2.10. NeuraLight
    • 8.2.10.1. Company overview
    • 8.2.10.2. Financial performance
    • 8.2.10.3. Product benchmarking
    • 8.2.10.4. Strategic initiatives